American masters cyclist banned for eight years after second doping offence
Kayle LeoGrande banned for eight years after testing positive for seven banned substances
Kayle LeoGrande has been banned for eight years after testing positive for seven banned substances after winning the Dana Point Grand Prix criterium in California on April 30th, 2017.
LeoGrande, 40, tested positive for raloxifene, ostarine, ibutamoren, GW1516 sulfone, RAD140, LGD4033, and andarine in an in-competition test.
“Raloxifene and GW1516 sulfone, a metabolite of GW1516, are prohibited substances in the class of Hormone and Metabolic Modulators; ostarine, RAD140, LGD4033 and andarine, are prohibited substances in the class of Anabolic Agents; and ibutamoren is a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics,” a U.S Anti-Doping (USADA) statement explained.
It was the second time that LeoGrande had been caught using banned substances, USADA announced that he would be banned for eight years.
Leogrande was embroiled in a doping scandal in 2008, when it was alleged that he confessed his use of performance-enhancing drugs to a team staffer when competing at Superweek in July 2007. Leogrande vigorously contested the charges brought against him by the United States Anti-Doping Agency (USADA), but was suspended for two years after a three-member arbitration panel concluded he had used EPO.